Tag:
Calando Pharmaceuticals
Latest Headlines
Latest Headlines
Cerulean pockets $10M as it catapults into the clinic
With the ink still drying on a new deal to license in nanoparticle technology developed by Calando Pharmaceuticals, Cerulean Pharma is set to announce later this morning that it has gone back to the
Calando inks licensing deal with Cerulean
Calando Pharmaceuticals, a subsidiary of Arrowhead Research, has struck a licensing deal with Cerulean Pharma for Calando's drug delivery platform, Cyclosert, and the associated clinical stage
